DOI: 10
The exact mechanism of finasteride’s beneficial effect on BPH-related
PubMed Effects of finasteride on hematuria associated with benign prostatic hyperplasia: long-term follow-up
The effect of finasteride on the expression of vascular endothelial growth factor
Hematuria resolved in 86% of finasteride-treated patients, compared with only 37% of those who received placebo
Of note, in BPH, the use of finasteride may help resolve the hematuria
In this group, 3 patients had grade 1, 5 grade 2, and 4 grade 3 hematuria prior to treatment with finasteride
In this report we address an unusual adverse effect of finasteride (Propecia 1 mg tablets) that was associated with painless hematuria and hematospermia in a 38-year-old healthy male during treatment of androgenic alopecia at a dose of 1 mg/day
Twelve had undergone prior prostatectomy
Finasteride provides relief of symptoms related to benign prostatic hyperplasia
When causes are discovered, they might include: Urinary tract infections
Benign prostatic hyperplasia, or enlarged prostate
The efficacy of finasteride was assessed in the treatment of gross hematuria associated with benign prostatic hyperplasia (BPH)
Finasteride, a 5alpha-reductase inhibitor, slowly reduces prostatic volume but is not as effective as alpha blockers, especially in men with a smaller prostate
In 1 patient clot retention developed requiring transurethral resection of the prostate and 2 patients had 1 or more minor episodes of bleeding that resolved spontaneously
Methods: Forty-two patients with hematuria episodes due to
Finasteride appears to be an effective agent for controlling gross hematuria secondary to prostatic bleeding
Men with BPH usually have difficulty urinating, a decreased flow of urination, hesitation at the beginning of urination, and a need to get up at